Gvia^®

Therapeutic Segment:
Anti-diabetic

Generic Name:
Sitagliptin

Description:
Gvia Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme.

Indication:
For adult patients with type 2 diabetes mellitus, Sitagliptin is indicated to improve glycaemic control: as monotherapy • In patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance.

Formulation:

• Tablets

Strength:

• 50mg
• 100mg

Pack Size:

• 14’s